S100B and medulloblastoma: In this study, we examined 16 members of the S100 gene family for evidence of methylation-dependent epigenetic regulation in medulloblastoma, using a pharmacological expression reactivation approach, involving microarray analysis of gene expression changes induced by the treatment of medulloblastoma cell lines with inhibitors of DNA methylation.